表纸
市场调查报告书
商品编码
781815

全球主要国家的过敏性结膜炎市场:SAC、PAC、VKC、AKC、GPC

Global Allergic Conjunctivitis Market, Patients, Treated Patients, by Countries (India, China, Japan, US, UK, etc), Disease Type(SAC, PAC, VKC, AKC, GPC), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761, etc) Companies, Growth Drivers & Challenges

出版日期: | 出版商: Renub Research | 英文 127 Pages | 商品交期: 最快1-2个工作天内

价格
  • 全貌
  • 简介
  • 目录
简介

全球过敏性结膜炎的市场预测至2025年将成长到超过20亿美元的规模。

本报告提供全球过敏性结膜炎的市场调查,疾病概要,市场规模及患者数、治疗中的患者数的变化与预测,各疾病种类的市场占有率,各主要国家的详细分析,已上市药、开发平台药物的简介,市场成长的各种影响因素分析,主要企业的简介、配合措施等资料汇整。

第1章 摘要整理

第2章 过敏性结膜炎:全球市场规模、患者数

  • 过敏性结膜炎市场
  • 患者数
  • 治疗中的患者数

第3章 过敏性结膜炎市场:市场占有率的变化、预测

  • 各国占有率
  • 患者人口的占有率
  • 治疗中的患者数的占有率
  • 各疾病类型占有率

第4章 印度

  • 患者数
  • 治疗中的患者数
  • 过敏性结膜炎市场

第5章 中国

  • 患者数
  • 治疗中的患者数
  • 过敏性结膜炎市场

第6章 日本

  • 患者数
  • 治疗中的患者数
  • 过敏性结膜炎市场

第7章 美国

  • 患者数
  • 治疗中的患者数
  • 过敏性结膜炎市场

第8章 英国

  • 患者数
  • 治疗中的患者数
  • 过敏性结膜炎市场

第9章 法国

  • 患者数
  • 治疗中的患者数
  • 过敏性结膜炎市场

第10章 德国

  • 患者数
  • 治疗中的患者数
  • 过敏性结膜炎市场

第11章 义大利

  • 患者数
  • 治疗中的患者数
  • 过敏性结膜炎市场

第12章 西班牙

  • 患者数
  • 治疗中的患者数
  • 过敏性结膜炎市场

第13章 全球过敏性结膜炎市场:各疾病类型

  • 季节性过敏性结膜炎 (SAC)、全年性过敏性结膜炎 (PAC)
  • 春季粘膜炎 (VKC)
  • 特异反应性性角结膜炎 (AKC)
  • 巨大乳头结膜炎 (GPC)

第14章 已上市药、开发平台药物的简介

  • Zerviate
  • OTX-DP (Dexamethasone Insert)
  • ADX-102
  • PRT2761
  • CVXL-0074
  • AK-002
  • Bertilimumab
  • Reproxalap
  • ST-266
  • SYL-116011

第15章 成长推动因素

第16章 课题

第17章 Santen Pharmaceutical

  • 企业概要
  • 举措、配合措施
  • 财务分析

第18章 Alcon Inc. (Novartis)

  • 企业概要
  • 举措、配合措施
  • 财务分析

第19章 Portola Pharmaceuticals Inc.

  • 企业概要
  • 举措、配合措施
  • 财务分析

第20章 Ocular Therapeutix Inc.

  • 企业概要
  • 举措、配合措施
  • 财务分析
目录

Allergic conjunctivitis is a kind of eye disease in which it affect the eye surfaces and are commonly associated to immune-mediated inflammatory reactions of these structures. The prevalence of the allergic conjunctivitis is found more in summer and spring across the various regions. Pollen, dust, irritants such as cigarette smoke, perfumes etc. are some of the substance that triggers the conjunctivitis. Itching is the most typical sign of allergic conjunctivitis, and more than 75 percent of patients report this symptom when seeking treatment. According to Renub Research Allergic Conjunctivitis Market is expected to be more than USD 2 Billion market by 2025.

Global allergic conjunctivitis market will grow due to increasing prevalence of various allergic conjunctivitis, development in medical infrastructure in the developing countries, growing awareness about allergic conjunctivitis among people, increasing ageing population and upcoming therapies such as Zerviate, ADX-102, PRT-2761, OTX-DP etc. Allergic conjunctivitis are classified mainly in five types: Seasonal Allergic Conjunctivitis (SAC), Perennial Allergic Conjunctivitis (PAC), Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC) and Giant Papillary Conjunctivitis (GPC).

Renub Research report titled "Global Allergic Conjunctivitis Market, Patients, Treated Patients By Countries (India, China, Japan, United States, United Kingdom, France, Germany, Italy, Spain), Disease Type (Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC), Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC) And Giant Papillary Conjunctivitis (GPC)), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011) Companies (Santen Pharmaceutical, Alcon (Novartis), Portola Pharmaceuticals, Ocular Therapeutix), Growth Drivers, Challenges" provides a complete analysis of global allergic conjunctivitis market.

China Dominates the Global Allergic Conjunctivitis Patient Population

In this report, we have shown complete insight of country analysis of allergic conjunctivitis patient population. The covered countries are; India, China, Japan, United States, United Kingdom, France, Germany, Italy and Spain. China dominates the global allergic conjunctivitis patient population numbers.

United States is the leading Country in the Global Allergic Conjunctivitis Market

Allergic conjunctivitis market is growing across all parts of the world. Market growth rates varies in the countries covered in the report India, China, Japan, United States, United Kingdom, France, Germany, Italy and Spain. United States is leading country in the global allergic conjunctivitis market due to growing awareness, strong healthcare support system and large patient population.

Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Hold Majority of Market in the Global Allergic Conjunctivitis Market

On the basis of disease type, global Allergic conjunctivitis market is further segmented into seasonal allergic conjunctivitis (SAC) & perennial allergic conjunctivitis (PAC) market, vernal keratoconjunctivitis (VKC) market, atopic keratoconjunctivitis (AKC) market and giant papillary conjunctivitis (GPC) market, globally. Seasonal allergic conjunctivitis (SAC) & perennial allergic conjunctivitis (PAC) hold majority of market share in the global allergic conjunctivitis market.

Allergic Conjunctivitis Pipe Line Drugs are Key Strength for this Market Place

In the global allergic conjunctivitis market, allergic conjunctivitis pipe line drugs will play the major role for the growth of this market. At present several drugs such as Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011 etc. are in preclinical, IND, Phase I, Phase II and Phase III stage.

Report has been analyzed from 9 Major Viewpoints:

  • 1. Global Allergic Conjunctivitis Market
  • 2. Global Allergic Conjunctivitis Market Share, Disease Type Market Share, Patients Share, Treated Patients Share
  • 3. Country Allergic Conjunctivitis Market
  • 4. Country Allergic Conjunctivitis Patients Population
  • 5. Country Allergic Conjunctivitis Treated Patients Population
  • 6. Disease Type Allergic Conjunctivitis Market
  • 7. Allergic Conjunctivitis Drugs Pipeline
  • 8. Growth Drivers and Challenges
  • 9. Key Allergic Conjunctivitis Companies Initiatives and Financial Insight

Country Covered - Global Allergic Conjunctivitis Market

  • India
  • China
  • Japan
  • United States
  • United Kingdom
  • France
  • Germany
  • Italy
  • Spain

Disease Type Covered - Global Allergic Conjunctivitis Market

  • Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC)
  • Vernal Keratoconjunctivitis (VKC)
  • Atopic Keratoconjunctivitis (AKC)
  • Giant Papillary Conjunctivitis (GPC)

Drugs Profile Covered - Global Allergic Conjunctivitis Market

  • Zerviate
  • OTX-DP
  • ADX-102
  • PRT-2761
  • CVXL-0074
  • AK-002
  • Bertilimumab
  • Reproxalap
  • ST-266
  • SYL-116011

Company Covered

  • Santen Pharmaceutical
  • Alcon (Novartis)
  • Portola Pharmaceuticals
  • Ocular Therapeutix

Table of Contents

1. Executive Summary

2. Global Allergic Conjunctivitis Market and Patients Analysis

  • 2.1 Allergic Conjunctivitis Market
  • 2.2 Allergic Conjunctivitis Patient Numbers
  • 2.3 Allergic Conjunctivitis Treated Patient Numbers

3. Share Analysis - Global Allergic Conjunctivitis

  • 3.1 Country Market Share
  • 3.2 Patients Population Share
  • 3.3 Treated Patients Population Share
  • 3.4 By Disease Type Share

4. India

  • 4.1 Allergic Conjunctivitis Patient Numbers
  • 4.2 Allergic Conjunctivitis Treated Patient Numbers
  • 4.3 Allergic Conjunctivitis Market

5. China

  • 5.1 Allergic Conjunctivitis Patient Numbers
  • 5.2 Allergic Conjunctivitis Treated Patient Numbers
  • 5.3 Allergic Conjunctivitis Market

6. Japan

  • 6.1 Allergic Conjunctivitis Patient Numbers
  • 6.2 Allergic Conjunctivitis Treated Patient Numbers
  • 6.3 Allergic Conjunctivitis Market

7. United States

  • 7.1 Allergic Conjunctivitis Patient Numbers
  • 7.2 Allergic Conjunctivitis Treated Patient Numbers
  • 7.3 Allergic Conjunctivitis Market

8. United Kingdom

  • 8.1 Allergic Conjunctivitis Patient Numbers
  • 8.2 Allergic Conjunctivitis Treated Patient Numbers
  • 8.3 Allergic Conjunctivitis Market

9. France

  • 9.1 Allergic Conjunctivitis Patient Numbers
  • 9.2 Allergic Conjunctivitis Treated Patient Numbers
  • 9.3 Allergic Conjunctivitis Market

10. Germany

  • 10.1 Allergic Conjunctivitis Patient Numbers
  • 10.2 Allergic Conjunctivitis Treated Patient Numbers
  • 10.3 Allergic Conjunctivitis Market

11. Italy

  • 11.1 Allergic Conjunctivitis Patient Numbers
  • 11.2 Allergic Conjunctivitis Treated Patient Numbers
  • 11.3 Allergic Conjunctivitis Market

12. Spain

  • 12.1 Allergic Conjunctivitis Patient Numbers
  • 12.2 Allergic Conjunctivitis Treated Patient Numbers
  • 12.3 Allergic Conjunctivitis Market

13. Disease Type - Global Allergic Conjunctivitis Market

  • 13.1 Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC)
  • 13.2 Vernal Keratoconjunctivitis (VKC)
  • 13.3 Atopic Keratoconjunctivitis (AKC)
  • 13.4 Giant Papillary Conjunctivitis (GPC)

14. Global Allergic Conjunctivitis Drugs Profile/Pipe Line Drugs

  • 14.1 Zerviate
  • 14.2 OTX-DP (Dexamethasone Insert)
  • 14.3 ADX-102
  • 14.4 PRT2761
  • 14.5 CVXL-0074
  • 14.6 AK-002
  • 14.7 Bertilimumab
  • 14.8 Reproxalap
  • 14.9 ST-266
  • 14.10 SYL-116011

15. Growth Driver

  • 15.1 Rapid Urbanization and Growth of Particulate Pollution
  • 15.2 Increasing Ageing Population & Widespread Use of Medications for Various Eye Diseases

16. Challenges

  • 16.1 Diagnostic Challenges
  • 16.2 Undertreated by Patients

17. Santen Pharmaceutical

  • 17.1 Company Overview
  • 17.2 Initiatives
    • 17.2.1 Point 1
    • 17.2.2 Point 2
  • 17.3 Financial Insight

18. Alcon Inc. (Novartis)

  • 18.1 Company Overview
  • 18.2 Initiatives
    • 18.2.1 Point 1
    • 18.2.2 Point 2
  • 18.3 Financial Insight

19. Portola Pharmaceuticals Inc.

  • 19.1 Company Overview
  • 19.2 Initiatives
    • 19.2.1 Point 1
    • 19.2.2 Point 2
  • 19.3 Financial Insight

20. Ocular Therapeutix Inc.

  • 20.1 Company Overview
  • 20.2 Initiatives
    • 20.2.1 Point 1
    • 20.2.2 Point 2
  • 20.3 Financial Insight

List of Figures:

Figure 2 1: Global - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 2 2: Global - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 2 3: Global - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 2 4: Global - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 2 5: Global - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 2 6: Global - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 3 1: Global - Allergic Conjunctivitis Market Country Share (Percent), 2013 - 2018

Figure 3 2: Global - Forecast for Allergic Conjunctivitis Market Country Share (Percent), 2019 - 2025

Figure 3 3: Global - Allergic Conjunctivitis Treated Patients Population Country Share (Percent), 2013 - 2018

Figure 3 4: Global - Forecast for Allergic Conjunctivitis Treated Patients Population Country Share (Percent), 2019 - 2025

Figure 3 5: Global - Allergic Conjunctivitis Disease Type Market Share (Percent), 2013 - 2018

Figure 3 6: Global - Forecast for Allergic Conjunctivitis Disease Type Market Share (Percent), 2019 - 2025

Figure 4 1: India - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 4 2: India - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 4 3: India - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 4 4: India - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 4 5: India - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 4 6: India - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 5 1: China - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 5 2: China - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 5 3: China - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 5 4: China - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 5 5: China - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 5 6: China - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 6 1: Japan - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 6 2: Japan - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 6 3: Japan - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 6 4: Japan - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 6 5: Japan - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 6 6: Japan - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 7 1: United States - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 7 2: United States - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 7 3: United States - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 7 4: United States - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 7 5: United States - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 7 6: United States - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 8 1: United Kingdom - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 8 2: United Kingdom - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 8 3: United Kingdom - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 8 4: United Kingdom - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 8 5: United Kingdom - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 8 6: United Kingdom - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 9 1: France - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 9 2: France - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 9 3: France - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 9 4: France - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 9 5: France - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 9 6: France - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 10 1: Germany - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 10 2: Germany - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 10 3: Germany - Allergic Conjunctivitis Patient Treated Numbers (Million), 2013 - 2018

Figure 10 4: Germany - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 10 5: Germany - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 10 6: Germany - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 11 1: Italy - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 11 2: Italy - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 11 3: Italy - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 11 4: Italy - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 11 5: Italy - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 11 6: Italy - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 12 1: Spain - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 12 2: Spain - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 12 3: Spain - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 12 4: Spain - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 12 5: Spain - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 12 6: Spain - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 13 1: Global - Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2013 - 2018

Figure 13 2: Global - Forecast for Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2019 - 2025

Figure 13 3: Global - Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2013 - 2018

Figure 13 4: Global - Forecast for Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2019 - 2025

Figure 13 5: Global - Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2013 - 2018

Figure 13 6: Global - Forecast for Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2019 - 2025

Figure 13 7: Global - Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2013 - 2018

Figure 13 8: Global - Forecast for Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2019 - 2025

Figure 14 1: Allergic Conjunctivitis Pipe Line Drug - Zerviate Status (2018)

Figure 14 2: Allergic Conjunctivitis Pipe Line Drug - OTX-DP (Dexamethasone Insert) Status (2018)

Figure 14 3: Allergic Conjunctivitis Pipe Line Drug - ADX-102 Status (2018)

Figure 14 4: Allergic Conjunctivitis Pipe Line Drug - PRT-2761Status (2018)

Figure 14 5: Allergic Conjunctivitis Pipe Line Drug - CVXL-0074 Status (2018)

Figure 14 6: Allergic Conjunctivitis Pipe Line Drug - AK-002 Status (2018)

Figure 14 7: Allergic Conjunctivitis Pipe Line Drug - Bertilimumab Status (2018)

Figure 14 8: Allergic Conjunctivitis Pipe Line Drug - Reproxalap Status (2018)

Figure 14 9: Allergic Conjunctivitis Pipe Line Drug - ST-266 Status (2018)

Figure 14 10: Allergic Conjunctivitis Pipe Line Drug - SYL-116011 Status (2018)

Figure 17 1: Santen Pharmaceutical - Global Revenue (Million US$), 2014 - 2018

Figure 17 2: Santen Pharmaceutical - Forecast for Global Revenue (Million US$), 2019 - 2025

Figure 18 1: Alcon (Novartis) - Global Revenue (Million US$), 2014 - 2018

Figure 18 2: Alcon (Novartis) - Forecast for Global Revenue (Million US$), 2019 - 2025

Figure 19 1: Portola Pharmaceuticals - Global Revenue (Thousand US$), 2014 - 2018

Figure 19 2: Portola Pharmaceuticals - Forecast for Global Revenue (Thousand US$), 2019 - 2025

Figure 20 1: Ocular Therapeutix - Global Revenue (Thousand US$), 2014 - 2018

Figure 20 2: Ocular Therapeutix - Forecast for Global Revenue (Thousand US$), 2019 - 2025

List of Tables:

Table 3 1: Global - Allergic Conjunctivitis Patients Population Country Share (Percent), 2013 - 2018

Table 3 2: Global - Forecast for Allergic Conjunctivitis Patients Population Country Share (Percent), 2019 - 2025